Skip to main content
Premium Trial:

Request an Annual Quote

Roche Files Suit Against Enzo After Offer to Settle Falls Through

NEW YORK, June 3 (GenomeWeb News) - Roche Diagnostics and Roche Molecular Systems are suing Enzo Biochem and Enzo Life Sciences to strike down Enzo's claims to  microarray-related technologies, Enzo said today. The suit was filed after Enzo rejected a cash settlement offer from Roche as inadequate.


Enzo said it "will vigorously protect its assets and rights and will respond appropriately to this action."


Enzo claims that Roche broke a distribution and supply agreement the two companies signed in 1994, and that certain products and technologies "that were funneled by Affymetrix Inc. to Roche" belong to Enzo under an agreement the company has with Affymetrix.


The disputed technology relates to Enzo's US patent 4,994,373,  "Method and structures employing chemically-labelled polynucleotide probes", which is also the subject of a lawsuit by Enzo against Affymetrix.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.